The Oncology Institute, Inc. TOI
Set alert
5.13 USD 0.00 0.00%
At close · Aug 3
5.28 +0.15 +2.92%
After hours · Aug 3, 4:00 PM ET
4.87 Day range 5.15
0.125 52-week range 2.50
- YTD
- +44.10%
- 1 year
- +129.02%
- Open
- 4.94
- Prev close
- 5.13
- Mkt cap
- 15.42M
- Vol
- 1.21M
- Avg vol
- 1.67M
- EPS
- -0.77
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.87
- High
- 5.15
- Forward P/E
- -1.28
- Beta
- 0.62
- Short ratio
- 3.38
- Inst. own
- 47.59%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.24794
- 200-d avg
- 0.5979
- 1y target
- 0.00
2Y chart
Events in this range
- Aug 13, 2024Earnings: -0.17; estimate -0.1; surprise -70%
- Nov 13, 2024Earnings: -0.18; estimate 0; surprise —%
Signals (83)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Jul 28, 2026 | 3 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 24, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 16, 2026 | 3 months ago |
| RSI: Overbought | Jul 13, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 7, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 2, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 29, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 22, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 11, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 10, 2026 | 4 months ago |
| RSI: Overbought | Jun 8, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 5, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 3, 2026 | 5 months ago |
| MACD: Buy Signal | May 21, 2026 | 5 months ago |
| RSI: Overbought | May 21, 2026 | 5 months ago |
| MACD: Sell Signal | May 18, 2026 | 5 months ago |
| RSI: Overbought | May 1, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 29, 2026 | 6 months ago |
| SMA: Bullish | Apr 28, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 24, 2026 | 6 months ago |
| SMA: Bearish | Apr 23, 2026 | 6 months ago |
| SMA: Bullish | Apr 22, 2026 | 6 months ago |
| SMA: Bearish | Apr 21, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 14, 2026 | 6 months ago |
| SMA: Bullish | Mar 31, 2026 | 7 months ago |
| SMA: Bearish | Mar 30, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 27, 2026 | 7 months ago |
| SMA: Bearish | Mar 20, 2026 | 7 months ago |
| SMA: Bullish | Mar 16, 2026 | 7 months ago |
| SMA: Bullish | Mar 16, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 18, 2026 | 8 months ago |
| RSI: Oversold | Feb 5, 2026 | 8 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bearish | Jan 23, 2026 | 9 months ago |
| SMA: Bullish | Jan 22, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 14, 2026 | 9 months ago |
| SMA: Bearish | Jan 13, 2026 | 9 months ago |
| SMA: Bullish | Jan 2, 2026 | 10 months ago |
| SMA: Bearish | Dec 17, 2025 | 10 months ago |
| SMA: Bullish | Dec 11, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 8, 2025 | 10 months ago |
| SMA: Bullish | Nov 14, 2025 | 11 months ago |
| RSI: Oversold | Nov 13, 2025 | 11 months ago |
| SMA: Bearish | Nov 7, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 4, 2025 | 12 months ago |
| RSI: Overbought | Oct 22, 2025 | 1 year ago |
| SMA: Bullish | Oct 3, 2025 | 1 year ago |
| SMA: Bearish | Sep 25, 2025 | 1 year ago |
| SMA: Bullish | Sep 24, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 22, 2025 | 1 year ago |
| SMA: Bearish | Sep 2, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 14, 2025 | 1 year ago |
| RSI: Overbought | Aug 7, 2025 | 1 year ago |
| RSI: Overbought | Aug 4, 2025 | 1 year ago |
| RSI: Overbought | Jul 17, 2025 | 1 year ago |
| SMA: Bullish | Jul 10, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 3, 2025 | 1 year ago |
| SMA: Bearish | Jun 13, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 3, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 2, 2025 | 1 year ago |
| MACD: Sell Signal | May 2, 2025 | 1 year ago |
| RSI: Overbought | Apr 10, 2025 | 1 year ago |
| RSI: Overbought | Apr 2, 2025 | 1 year ago |
| RSI: Overbought | Mar 24, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 19, 2025 | 1 year ago |
| SMA: Bullish | Mar 18, 2025 | 1 year ago |
| SMA: Bearish | Mar 10, 2025 | 1 year ago |
| SMA: Bullish | Mar 7, 2025 | 1 year ago |
| SMA: Bearish | Mar 6, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 12, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 10, 2025 | 1 year ago |
| RSI: Overbought | Feb 10, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 7, 2025 | 1 year ago |
| RSI: Overbought | Feb 6, 2025 | 1 year ago |
| RSI: Overbought | Jan 14, 2025 | 1 year ago |
| RSI: Overbought | Dec 27, 2024 | 1 year ago |
| SMA: Bullish | Dec 26, 2024 | 1 year ago |
| MACD: Buy Signal | Dec 3, 2024 | 1 year ago |
| RSI: Oversold | Nov 15, 2024 | 1 year ago |
| MACD: Sell Signal | Oct 30, 2024 | 2 years ago |
| SMA: Bearish | Oct 29, 2024 | 2 years ago |
| SMA: Bullish | Oct 18, 2024 | 2 years ago |
Key statistics
- Market cap
- 15.42M
- Enterprise value
- 92.40M
- Trailing P/E
- 0.00
- Forward P/E
- -1.28
- PEG ratio
- 0.00
- Price / sales
- 0.04
- Price / book
- 0.27
- EPS (TTM)
- -0.77
- Beta
- 0.62
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -19.81%
- Revenue (TTM)
- 361.07M
- Revenue growth
- 22.90%
- Free cash flow
- -23.95M
- Total cash
- 46.36M
- Total debt
- 121.01M
- Return on equity
- -125.59%
- Shares outstanding
- 75.56M
- Short % of float
- 0.50%
- 50-day average
- 0.24794
- 200-day average
- 0.5979
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
TOI Revenue — quarterly 161.28M
TOI Net income — quarterly -8.24M
TOI EPS — quarterly -0.08
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | 0.00 | -0.18 | — | — |
| Aug 13, 2024 | Jun 1, 2024 | -0.10 | -0.17 | -0.07 | -70.00% |
| May 14, 2024 | Mar 1, 2024 | -0.12 | -0.22 | -0.10 | -83.33% |
| Mar 27, 2024 | Dec 1, 2023 | -0.11 | -0.21 | -0.10 | -90.91% |
| Nov 8, 2023 | Sep 1, 2023 | -0.13 | -0.19 | -0.06 | -46.15% |
| Aug 8, 2023 | Jun 1, 2023 | -0.17 | -0.19 | -0.02 | -11.76% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 16, 2023 | Guggenheim | main | — | Buy |
| Mar 20, 2023 | Guggenheim | main | — | Neutral |
| Nov 11, 2022 | Guggenheim | main | — | Buy |
| Aug 15, 2022 | Jefferies | init | — | Buy |
About The Oncology Institute, Inc.
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- theoncologyinstitute.com
News
- BlackRock Inc. Buys Shares of 4,749,030 The Oncology Institute, Inc. $TOI
- Head to Head Contrast: RadNet (NASDAQ:RDNT) and Oncology Institute (NASDAQ:TOI)
- Oncology Institute Q2 Earnings Call Highlights
- The Oncology Institute Rebrands as Starling Oncology
- The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call
- Best Cheap Stocks Under $10 to Buy Now in July
- The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity
- 2 More Stocks to Buy for the AI Convergence
- The Oncology Institute (TOI) Soars 5.3%: Is Further Upside Left in the Stock?
- 3 Stocks to Buy for the AI Convergence
Your note
Sign in to keep a note on TOI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARASCH RICHARD A | Director | Stock Award(Grant) | Nov 21, 2024 | 417,193 |
| HIVELY BRAD | Director | Purchase | Dec 1, 2024 | 666,753 |
| JOHNSON KAREN MARIE | Director | Stock Award(Grant) | Nov 21, 2024 | 167,185 |
| KAUSHAL MOHIT | Director | Stock Award(Grant) | Nov 21, 2024 | 177,253 |
| LING GABRIEL | Director | Stock Award(Grant) | Nov 21, 2024 | 109,057 |
| MCGEORGE ANNE | Director | Stock Award(Grant) | Nov 21, 2024 | 183,346 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 6.29% | 4,749,900 | 969.45K | Sep 29, 2024 |
| Deerfield Management Company, L.P. (Series C) | 4.45% | 3,360,052 | 685.79K | Sep 29, 2024 |
| TIFF Advisory Services, Inc. | 3.48% | 2,632,885 | 537.37K | Sep 29, 2024 |
| Cincinnati Insurance Company | 2.69% | 2,034,045 | 415.15K | Sep 29, 2024 |
| Kent Lake PR LLC | 2.65% | 2,000,000 | 408.20K | Sep 29, 2024 |
| Vanguard Group Inc | 2.36% | 1,783,454 | 364.00K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Growth Company Fund | 2.38% | 1,799,480 | 367.27K | Oct 30, 2024 |
| Vanguard Total Stock Market Index Fund | 1.69% | 1,273,384 | 259.90K | Sep 29, 2024 |
| Fidelity Growth Company K6 Fund | 0.57% | 431,188 | 88.00K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.56% | 422,983 | 86.33K | Sep 29, 2024 |
| Fidelity Series Growth Company Fund | 0.50% | 377,375 | 77.02K | Oct 30, 2024 |
| Fidelity Extended Market Index Fund | 0.25% | 192,244 | 39.24K | Oct 30, 2024 |